Important update in Shingles prevention with Shingrix

Date: Wednesday November 2 2022
Time: 7:00pm – 8:00pm AEDT

Join Prof. Tony Cunningham for an overview of shingles and the development of SHINGRIX,
including an update on key new data around SHINGRIX’s duration of prevention and how you
can help prevent shingles in your patients.

GSK invites you to attend an upcoming live webinar where Prof. Tony Cunningham will provide an overview of shingles and the development of SHINGRIX (Recombinant Varicella Zoster Virus glycoprotein E antigen (AS01b adjuvant vaccine)), with a hot off the press update on new long term follow-up data for shingles prevention.
Learning Objectives:

1. Discuss the impact of shingles on patients and identify who is at risk.
2. Evaluate the scientific rationale and innovation behind SHINGRIX, and examine its clinical profile
3. Analyse the long term follow-up data for SHINGRIX
4. Develop strategies for integrating SHINGRIX into your practice

Follow the link to register.